Neurosurgeon: My Patients Show Me Real Heroism and Resilience
March 11, 2024
UC San Diego Health provides the most advanced neurological cancer care by combining leading-edge surgical techniques and the latest technology.
Your search for “Cancer Immunotherapy” returned 120 results
Extrachromosomal DNA is common in human cancer and drives poor patient outcomes
August 17, 2020
The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including the University of California San Diego.
Strauss Family Gives UC San Diego $1 Million to Help Develop a Cancer Vaccine
October 17, 2017
…the doctors at Moores Cancer Center at UC San Diego Health. When their daughter’s cancer reappeared, it was the first place they turned for help. Because of their experience and trust in the medical and research staff, the couple recently donated $1 million to the University of California San Diego…
UC San Diego Biologists Discover Process That Neutralizes Tumors
July 10, 2018
…function. The unexpected mechanism could help determine whether a cancer patient will respond to immunotherapy.
10 Cancer Moonshot Blue Ribbon Panel Recommendations Embraced by NCI
September 7, 2016
…to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiative, they were given five months to draft guidelines to accelerate cancer research, prevention and care. On Wednesday, the National Cancer Advisory Board approved the Blue Ribbon Panel’s 10 recommendations.
CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction
February 23, 2016
Cancer immunology is based upon boosting the body’s own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified…
UC San Diego Health Offers Novel Gene Therapy for Bladder Cancer
July 8, 2024
UC San Diego Health is the first health system in San Diego County to offer novel gene therapy for bladder cancer.
Genetic Changes in Head and Neck Cancer, Immunotherapy Resistance Identified
April 26, 2021
A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
Philanthropists Ignite the Fight Against Cancer at SPARK Gala April 16
April 12, 2016
…in the fight against cancer, the University of California San Diego’s Moores Cancer Center will host its annual SPARK Gala on Saturday, April 16 at the Fairmont Grand Del Mar. The evening will include a three-course dinner with wine pairings, a live luxury auction and dancing. All proceeds will benefit…
UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers
December 3, 2018
Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.
